385 related articles for article (PubMed ID: 32170105)
41. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
[TBL] [Abstract][Full Text] [Related]
42. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.
Qin X; Song Y
Med Sci Monit; 2020 May; 26():e921815. PubMed ID: 32435051
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA network analysis identifies key microRNAs and genes associated with precancerous lesions of gastric cancer.
Wang XW; Wu Y; Wang D; Qin ZF
Genet Mol Res; 2014 Oct; 13(4):8695-703. PubMed ID: 25366760
[TBL] [Abstract][Full Text] [Related]
44. Hsa-miR-21 and Hsa-miR-29 in Tissue as Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer.
Wang D; Fan Z; Liu F; Zuo J
Cell Physiol Biochem; 2015; 37(4):1454-62. PubMed ID: 26509997
[TBL] [Abstract][Full Text] [Related]
45. MiR-204 down-regulation elicited perturbation of a gene target signature common to human cholangiocarcinoma and gastric cancer.
Canu V; Sacconi A; Lorenzon L; Biagioni F; Lo Sardo F; Diodoro MG; Muti P; Garofalo A; Strano S; D'Errico A; Grazi GL; Cioce M; Blandino G
Oncotarget; 2017 May; 8(18):29540-29557. PubMed ID: 28199974
[TBL] [Abstract][Full Text] [Related]
46. Identification of Potential Biomarkers Involved in Gastric Cancer Through Integrated Analysis of Non-Coding RNA Associated Competing Endogenous RNAs Network.
Xing C; Cai Z; Gong J; Zhou J; Xu J; Guo F
Clin Lab; 2018 Oct; 64(10):1661-1669. PubMed ID: 30336538
[TBL] [Abstract][Full Text] [Related]
47. [Construction and analysis of competitive endogenous RNA regulatory network related to gastric cancer].
Li R; Jiang WJ; Jin SL; Zhao RH; Cao XG; Zong H
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):115-121. PubMed ID: 32135645
[No Abstract] [Full Text] [Related]
48. MiR 21-5p as a predictor of recurrence in young gastric cancer patients.
Park SK; Park YS; Ahn JY; Do EJ; Kim D; Kim JE; Jung K; Byeon JS; Ye BD; Yang DH; Park SH; Hwang SW; Jung HY; Myung SJ
J Gastroenterol Hepatol; 2016 Aug; 31(8):1429-35. PubMed ID: 26824898
[TBL] [Abstract][Full Text] [Related]
49. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
50. Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients.
Sun T; Wang D; Ping Y; Sang Y; Dai Y; Wang Y; Liu Z; Duan X; Tao Z; Liu W
Int J Oncol; 2020 Feb; 56(2):460-469. PubMed ID: 31894266
[TBL] [Abstract][Full Text] [Related]
51. Serum miR-200c expression level as a prognostic biomarker for gastric cancer.
Zhang HP; Sun FB; Li SJ
Genet Mol Res; 2015 Dec; 14(4):15913-20. PubMed ID: 26662382
[TBL] [Abstract][Full Text] [Related]
52. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
Xiaoli Z; Yawei W; Lianna L; Haifeng L; Hui Z
Med Sci Monit; 2015 Dec; 21():3748-59. PubMed ID: 26628405
[TBL] [Abstract][Full Text] [Related]
53. Bioinformatics prediction and experimental validation of a novel microRNA: hsa-miR-B43 within human CDH4 gene with a potential metastasis-related function in breast cancer.
Rahimi A; Sedighi R; Emadi-Baygi M; Honardoost MA; Mowla SJ; Khanahmad H; Nikpour P
J Cell Biochem; 2020 Feb; 121(2):1307-1316. PubMed ID: 31489987
[TBL] [Abstract][Full Text] [Related]
54. Screening and Survival Analysis of Hub Genes in Gastric Cancer Based on Bioinformatics.
Zheng S; Yang L; Dai Y; Jiang L; Wei Y; Wen H; Xu Y
J Comput Biol; 2019 Nov; 26(11):1316-1325. PubMed ID: 31233344
[No Abstract] [Full Text] [Related]
55. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
56. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
Zeng Y; Wang KX; Xu H; Hong Y
J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
[TBL] [Abstract][Full Text] [Related]
57. Downregulation of microRNA-376a in Gastric Cancer and Association with Poor Prognosis.
Zhang C; Liang Y; Ma MH; Wu KZ; Zhang CD; Dai DQ
Cell Physiol Biochem; 2018; 51(5):2010-2018. PubMed ID: 30522118
[TBL] [Abstract][Full Text] [Related]
58. Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer.
Yang Y; Qu A; Zhao R; Hua M; Zhang X; Dong Z; Zheng G; Pan H; Wang H; Yang X; Zhang Y
Mol Oncol; 2018 Dec; 12(12):2072-2084. PubMed ID: 30242969
[TBL] [Abstract][Full Text] [Related]
59. Identification of MEG8/miR-378d/SOBP axis as a novel regulatory network and associated with immune infiltrates in ovarian carcinoma by integrated bioinformatics analysis.
Lei J; He ZY; Wang J; Hu M; Zhou P; Lian CL; Hua L; Wu SG; Zhou J
Cancer Med; 2021 Apr; 10(8):2924-2939. PubMed ID: 33742531
[TBL] [Abstract][Full Text] [Related]
60. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
